arrow
A

Aldo P. Maggioni

anmco research center
H指数:155
被引数:13.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Contemporary invasive management and in-hospital outcomes of acute myocardial infarction in patients with active or prior cancer: insights from the EYESHOT-2 registry

当代对活动性或既往癌症患者急性心肌梗死进行侵入性管理及院内结局:EYESHOT-2注册研究的启示

2026-09-170
PRE
Identifying barriers to lipoprotein(a) testing in secondary cardiovascular prevention and co-designing implementation strategies: an Italian behavior change wheel-informed study

识别脂蛋白(a)检测在二级心血管预防中的障碍并共同设计实施策略:一项基于意大利行为改变轮的研究

2026-09-100
OA
HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics

HPS-4/TIMI 65/ORION-4:一项双盲、随机、安慰剂对照试验,评估依洛尤单抗对动脉粥样硬化性心血管疾病患者临床结局的影响:试验设计、招募和基线特征

2026-09-010
PRE
ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey

欧洲心脏学会关于冠状动脉心脏病的预防与康复指南及当前实践:EUROASPIRE VI调查

2026-08-290
OAAI
Rationale, design, and experiences from the vanguard phase of the bariatric surgery for the reduction of cardiovascular events (BRAVE) trial

BRAVE试验先锋阶段减肥手术减少心血管事件的原理、设计与经验

2026-08-010
PRE
Statin use and LDL cholesterol target attainment in people with HIV after European AIDS Clinical Society 2024 guideline updates

他汀类药物使用及2024年欧洲艾滋病临床学会指南更新后HIV感染者中LDL胆固醇目标达成情况

2026-07-250
OAAI
Sustainable and Effective Lipid-Lowering Management: Prevention Strategies from the BRING-UP Prevention Study

可持续且有效的降脂管理:BRING-UP 预防研究中的预防策略

2026-02-080
OAAI
Clinical characteristics, management and outcomes of enterococcal infective endocarditis: an ancillary study from the ESC-EORP EURO-ENDO registry
2025-11-270
PRE
Effects of calcium channel blockers on GDMT prescription and outcomes according to ejection fraction: IN-HF real world data

钙通道阻滞剂对GDMT处方及射血分数相关结局的影响:IN-HF真实世界数据

2025-11-130
PRE
Future myocardial infarction after an acute coronary syndrome and pharmacogenetic response to dalcetrapib

急性冠脉综合征后未来心肌梗死及dalcetrapib的药代遗传学反应

2025-11-010
PRE
Diet and Clinical Outcomes in a Heart Failure Population

饮食与心力衰竭人群的临床结局

2025-10-290
PRE
Age- and sex-related differences in heart failure characteristics and treatment patterns across the ejection fraction spectrum: first data from the BRING-UP 3 Heart Failure study

年龄和性别相关的差异在射血分数谱中的心力衰竭特征和治疗模式:BRING-UP 3 心力衰竭研究的第一手数据

2025-10-010
PRE
Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF

沙库巴曲缬沙坦及采用EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS)评估的生活质量,在HFrEF和HFmrEF/HFpEF患者中的研究。

2025-09-010
OA